Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
PLoS One ; 16(12): e0261236, 2021.
Article de Anglais | MEDLINE | ID: mdl-34936650

RÉSUMÉ

In the past year, the global epidemic situation is still not optimistic, showing a trend of continuous expansion. With the research and application of vaccines, there is an urgent need to develop some optimal vaccination strategies. How to make a reasonable vaccination strategy to determine the priority of vaccination under the limited vaccine resources to control the epidemic and reduce human casualties? We build a dynamic model with vaccination which is extended the classical SEIR model. By fitting the epidemic data of three countries-China, Brazil, Indonesia, we have evaluated age-specific vaccination strategy for the number of infections and deaths. Furthermore, we have evaluated the impact of age-specific vaccination strategies on the number of the basic reproduction number. At last, we also have evaluated the different age structure of the vaccination priority. It shows that giving priority to vaccination of young people can control the number of infections, while giving priority to vaccination of the elderly can greatly reduce the number of deaths in most cases. Furthermore, we have found that young people should be mainly vaccinated to reduce the number of infections. When the emphasis is on reducing the number of deaths, it is important to focus vaccination on the elderly. Simulations suggest that appropriate age-specific vaccination strategies can effectively control the epidemic, both in terms of the number of infections and deaths.


Sujet(s)
Vaccins contre la COVID-19/administration et posologie , COVID-19/prévention et contrôle , Priorités en santé/tendances , Facteurs âges , Brésil/épidémiologie , COVID-19/épidémiologie , COVID-19/immunologie , Chine/épidémiologie , Humains , Indonésie/épidémiologie , Modèles théoriques , SARS-CoV-2/immunologie , SARS-CoV-2/pathogénicité , Vaccination/méthodes , Vaccination/psychologie , Vaccination/tendances , Vaccins/administration et posologie , Vaccins/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE